Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.
Journal: Genes, chromosomes & cancer
Published: August 17, 2022
Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome.
Journal: International journal of cancer
Published: November 09, 2021
A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 14, 2021
Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer.
Journal: International journal of cancer
Published: March 11, 2021
Showing 1-6 of 6
Last Updated: 09/26/2026